Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
1 091,511 090,401 090,401 073,69
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
610,11610,11610,29606,17
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
1 237,981 237,831 252,411 225,03
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
1 744,711 740,951 747,291 721,57
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
640,18639,92643,19634,73
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
849,58845,27851,68839,47
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
217,48217,48218,16215,51
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
3 260,693 273,363 287,813 240,78
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
942,45939,39948,80933,98
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
1 466,801 464,701 467,191 458,36
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
2 397,502 395,032 412,012 370,64
Q1 2026 earnings • in 2 days
See details
CRL:NYSE
Charles River Lbrtrs ntrntl Inc
172,32 $
+3,94%
(+6,54) 1D
172,34 $
+0,01% (+0,020)
Pre-market
Closed: 4 մյս, 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRL...
Open
164,77 $
High
172,66 $
Low
164,77 $
Mkt. cap
8,50 մլրդ
Avg. vol.
819,06 հզր
Volume
532,00
52-wk high
228,88 $
52-wk low
113,88 $
EPS
-2,91 $
Beta
1,45
Shares outstanding
49,34 մլն
No. of employees
19 հզր
News stories
From sources across the web
Profile
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
About Charles River Lbrtrs ntrntl Inc
CEOJames C. Foster
Employees19 հզր
Founded1947
HeadquartersWilmington, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitecriver.com
Next call 2 օրից
մյս 7, հնգ, 08:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1,94 est.)USD
Revenue / Estimate
-/ (977,71 մլն est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
984,17 մլն
1,03 մլրդ
1,00 մլրդ
994,23 մլն
Cost of goods sold
644,07 մլն
648,60 մլն
652,72 մլն
665,36 մլն
Cost of revenue
644,07 մլն
648,60 մլն
652,72 մլն
665,36 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
176,32 մլն
185,82 մլն
173,64 մլն
192,02 մլն
Operating expense
206,08 մլն
211,51 մլն
201,05 մլն
284,04 մլն
Total operating expenses
850,15 մլն
860,10 մլն
853,77 մլն
949,40 մլն
Operating income
134,01 մլն
172,03 մլն
151,08 մլն
44,83 մլն
Other non operating income
-3,61 մլն
154,00 հզր
-22,62 մլն
27,72 մլն
EBT including unusual items
35,98 մլն
71,42 մլն
87,20 մլն
-294,10 մլն
EBT excluding unusual items
95,32 մլն
143,32 մլն
104,48 մլն
35,18 մլն
Income tax expense
10,10 մլն
18,72 մլն
31,64 մլն
-17,81 մլն
Effective tax rate
28,07%
26,22%
36,29%
6,06%
Other operating expenses
-
-
-
-
Net income
25,47 մլն
52,33 մլն
54,42 մլն
-276,56 մլն
Net profit margin
2,59%
5,07%
5,42%
-27,82%
Earnings per share
2,34
3,12
2,43
2,39
Interest and investment income
1,40 մլն
1,10 մլն
1,42 մլն
1,02 մլն
Interest expense
-27,88 մլն
-29,97 մլն
-25,40 մլն
-23,78 մլն
Net interest expenses
-26,48 մլն
-28,87 մլն
-23,98 մլն
-22,76 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
218,88 մլն
327,04 մլն
165,25 մլն
169,61 մլն
Gain or loss from assets sale
-3,38 մլն
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more